• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

3-Furancarboxylic Acid, 5-Formyl-2-Methyl-, Ethyl Ester (CAS No. 19615-48-6): A Key Intermediate in Modern Pharmaceutical Synthesis

The compound 3-Furancarboxylic acid, 5-formyl-2-methyl-, ethyl ester, identified by its CAS number 19615-48-6, represents a significant intermediate in the realm of pharmaceutical chemistry. This molecule, characterized by its furan ring substituted with a formyl group at the 5-position and a methyl group at the 2-position, esterified at the carboxyl end, has garnered attention due to its versatile applications in drug development and synthetic organic chemistry.

At the core of its utility lies the presence of both electrophilic and nucleophilic sites, making it a valuable precursor for constructing more complex molecular architectures. The formyl group (—CHO) serves as a reactive handle for condensation reactions, while the ester moiety (—COOEt) provides stability and modularity in synthetic pathways. These features have positioned this compound as a cornerstone in the synthesis of various pharmacologically active agents.

In recent years, advancements in medicinal chemistry have highlighted the importance of furan derivatives in drug discovery. The 3-Furancarboxylic acid, 5-formyl-2-methyl-, ethyl ester has been employed in the development of novel therapeutic entities targeting diverse biological pathways. For instance, its structural motif is reminiscent of several natural products and bioactive molecules known for their antimicrobial, anti-inflammatory, and anticancer properties.

One notable application of this compound is in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs). The furan ring's ability to engage in hydrogen bonding interactions with biological targets makes it an attractive scaffold for designing molecules that modulate inflammatory responses. Researchers have leveraged the reactivity of the formyl group to introduce additional functional groups that enhance binding affinity and selectivity.

Furthermore, the 3-Furancarboxylic acid, 5-formyl-2-methyl-, ethyl ester has found utility in the preparation of kinase inhibitors, which are pivotal in treating cancers and other chronic diseases. The structural features of this compound allow for fine-tuning of pharmacokinetic properties, including solubility and metabolic stability. By modifying its derivatives, chemists have been able to develop lead compounds that exhibit potent inhibitory activity against specific kinases involved in disease progression.

Recent studies have also explored its role in antiviral drug development. The furan core is present in several known antiviral agents due to its ability to mimic natural sugars that are integral to viral replication cycles. The 5-formyl-2-methyl substitution pattern enhances interactions with viral enzymes, providing a rationale for further exploration as a scaffold for antiviral therapeutics.

The synthesis of this compound typically involves multi-step organic transformations starting from commercially available furan derivatives. Key steps include formylation at the 5-position using reagents such as Vilsmeier-Haack reagent or dimethylformamide (DMF) with phosphorus oxychloride (POCl?), followed by methylation at the 2-position via Birch reduction or direct alkylation methods. The final esterification step is commonly achieved using ethanol under acidic conditions or via transesterification reactions.

In industrial settings, process optimization is crucial to ensure high yields and purity while minimizing waste generation. Continuous flow chemistry has emerged as a promising approach for synthesizing such intermediates efficiently. This methodology not only enhances scalability but also aligns with green chemistry principles by reducing solvent usage and energy consumption.

The chemical properties of 3-Furancarboxylic acid, 5-formyl-2-methyl-, ethyl ester make it amenable to various analytical techniques for characterization. Nuclear magnetic resonance (NMR) spectroscopy, particularly proton (1H) and carbon (13C) NMR, provides detailed structural information about proton environments and carbon skeleton connectivity. Mass spectrometry (MS) aids in confirming molecular weight and fragmentation patterns, while infrared (IR) spectroscopy detects functional group vibrations characteristic of aldehydes and esters.

High-performance liquid chromatography (HPLC) or gas chromatography-mass spectrometry (GC-MS) are employed for purity assessment and quantification purposes. These techniques ensure that impurities arising from synthetic side reactions do not compromise downstream applications in pharmaceutical manufacturing.

The growing demand for 3-Furancarboxylic acid, 5-formyl-2-methyl-, ethyl ester underscores its importance as a building block in drug discovery pipelines. As research continues to uncover new therapeutic targets and mechanisms, compounds like this will remain indispensable tools for medicinal chemists seeking to design innovative treatments for unmet medical needs.

In conclusion, the CAS No. 19615-48-6 compound exemplifies how structurally diverse intermediates contribute to advancements in pharmaceutical science. Its unique combination of reactive sites and stability makes it a preferred choice for synthesizing biologically active molecules with potential therapeutic value across multiple disease areas.

• 32365-53-0(ethyl 5-formylfuran-3-carboxylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)